Cardiotrack Secures $2 Million in Pre-Series A Funding to Revolutionize Healthcare Screening

Cardiotrack, a healthcare screening company based in Bengaluru, secured $2 million in pre-Series A funding to expand its services to more health and life insurance providers. The company offers telemedicine kits, data analytics, and unique screening technologies, including a home-based equivalent of a treadmill test. This funding round follows a previous angel investment of $1.6 million, highlighting the strong potential of Cardiotrack's innovative approach to healthcare screening.

Cardiotrack, a leading provider of healthcare screening technology and services, has secured $2 million in pre-series A funding to fuel its mission of transforming the healthcare landscape. The funding round was led by seasoned angel investor Girish Narasimhan, with participation from Y S Shashidhar, Advisor at Dubai Holdings LLC.

This investment comes on the heels of a previous $1.6 million angel investment, demonstrating strong validation for Cardiotrack's innovative approach. The company, established in 2015, partners with health and life insurance providers to offer state-of-the-art telemedicine kits, advanced data analytics, and unique screening technologies, including a home-based equivalent of a treadmill test.

"We are thrilled to have secured this investment," said Avin Agarwal, Founder & CEO of Cardiotrack. "The funding validates our mission to drive positive change in healthcare and paves the way for further innovation and expansion."

Girish Narasimhan, who also serves as a member of the Cardiotrack board, is confident in the company's potential. "Avin and his team are deeply committed to revolutionizing healthcare screening, and their success in attracting leading insurance providers as clients is a testament to their value proposition," he remarked. "We strongly believe Cardiotrack will be at the forefront of shaping the future of healthcare."

This pre-series A funding will empower Cardiotrack to continue its growth trajectory, enhance its product offerings, and reach a wider audience. The company's commitment to data-driven healthcare solutions positions it as a key player in transforming the industry and improving the healthcare experience for both providers and patients.